Zydus Wellness growth ratios

·FMCG & RetailChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+46.2%+16.4%+3.2%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+34.2%+23.2%−8.6%
+3.3%+23.5%−8.9%
−43.2%+30.0%−14.0%
−88.6%+30.0%−14.0%
+60.0%+4.8%+5.4%
+2.7%+5.9%+4.6%
−40.4%+54.2%+168.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ZYDUSWELL₹479.50

Zydus Wellness Ltd.

· FMCG & Retail
₹ CrorePeersDABUREMAMILTDTATACONSUMLTFOODSHONASAGILLETTEEIDPARRYDOMSMcap ₹15,248 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—+3.2+16.4+46.2—
EBITDA Growth—-8.6+23.2+34.2—
EBIT Growth—-8.9+23.5+3.3—
Net Income Growth—-14.0+30.0-43.2—
EPS Growth—-14.0+30.0-88.6—
Total Assets Growth—+5.4+4.8+60.0—
Total Equity Growth—+4.6+5.9+2.7—
Cash from Operations Growth—+168.7+54.2-40.4—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.